© All rights reserved.
Optosurgical Optosurgical
  • About Us
    • Company Overview
    • Our Team
    • Careers
    • News
  • Technology
    • 3DMAV
    • Advancing Biliary Surgery
    • hANDY-i
  • Our Partners
  • Contact Us
Optosurgical
Home / Uncategorized / Optosurgical Received a $2.1M ARPA-H Phase II Extension Fund Award

Optosurgical Received a $2.1M ARPA-H Phase II Extension Fund Award

By Optosurgical Admin inUncategorized
15 Posts
Optosurgical Admin
  • Optosurgical participated in ISITES 2026 in Washington, D.C., where we presented our 3DMAV technology.
    Previous PostOptosurgical participated in ISITES 2026 in Washington, D.C., where we presented our 3DMAV technology.
  • Next PostOptosurgical to be a member of the Maryland Department of Commerce's delegation to AdvaMed's 2026 MedTech Conference.
    Optosurgical participated in ISITES 2026 in Washington, D.C., where we presented our 3DMAV technology.

Related Posts

Optosurgical to be a member of the Maryland Department of Commerce’s delegation to AdvaMed’s 2026 MedTech Conference.
Uncategorized

Optosurgical to be a member of the Maryland Department of Commerce’s delegation to AdvaMed’s 2026 MedTech Conference.

Optosurgical participated in ISITES 2026 in Washington, D.C., where we presented our 3DMAV technology.
Uncategorized

Optosurgical participated in ISITES 2026 in Washington, D.C., where we presented our 3DMAV technology.

Optosurgical participated in SPIE Photonics West 2026, engaging with global leaders in photonics, imaging, and medical technology.
Uncategorized

Optosurgical participated in SPIE Photonics West 2026, engaging with global leaders in photonics, imaging, and medical technology.

Optosurgical collaborated with MBA students from NYU Stern’s Entrepreneurship and Startup Association (ESA).
Uncategorized

Optosurgical collaborated with MBA students from NYU Stern’s Entrepreneurship and Startup Association (ESA).

Product

Company

Information

Subscribe to newsletter

© 2019 Scape Theme by Whitebox Studio
Copy